Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 21341-21342 [2019-09847]

Download as PDF khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 93 / Tuesday, May 14, 2019 / Notices (RFI) to inform potential revisions to the Consumer Assessment of Healthcare Providers and Systems Health Plan Survey 5.0. The Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Health Plan Survey 5.0 is one of the CAHPS family of surveys that assess patients’ experiences with health care providers, in different settings, and with health plans. The CAHPS surveys cover topics that are important to patients and that they are best able to assess, such as the communication with providers and access to health care services. This RFI requests public comment regarding the relevance and validity of the questions on CAHPS Health Plan Survey 5.0 (the Survey), and any user concerns about revisions to the Survey. DATES: Responses to the RFI must be received no later than June 13, 2019. ADDRESSES: Interested parties are to submit comments electronically to CAHPS1@westat.com with the subject line HP RFI. Non-electronic responses will also be accepted. Please mail to CAHPS; Westat; 1600 Research Blvd.; RB 1186S; Rockville, MD 20850. FOR FURTHER INFORMATION CONTACT: Questions may be addressed to Caren Ginsberg, Director, CAHPS Division, Center for Quality Improvement and Patient Safety, caren.ginsberg@ ahrq.hhs.gov, or (301) 427–1894. SUPPLEMENTARY INFORMATION: The last update of the Survey was in May 2012. AHRQ is considering an update to the Survey to ensure that the Survey questions continue to be relevant to Survey sponsors, users, patients, consumers, and other stakeholders. AHRQ is not seeking information on Survey administration methodology, public reporting, or Survey length with this request. AHRQ is seeking information on current uses of the Survey that reflects organization-specific perspectives, the impact of a potential Survey revision, and areas of the Survey that should and should not be modified. Respondents should refer to the questions with details on how such a Survey revision might affect the organization(s) they represent. Specific questions of interest to AHRQ include, but are not limited to, the following: 1. How and why does the respondent’s organization use the Survey? For example, is it used for adults, children, or both? In what languages is it administered? What supplemental items, if any, are used (e.g., children with chronic conditions or others)? 2. What is working well/what are the strengths of the Survey? VerDate Sep<11>2014 16:57 May 13, 2019 Jkt 247001 3. What content areas might be missing from the Survey? 4. What content areas on the Survey are no longer relevant or useful and why? 5. Are there new topic areas the Survey should address? 6. Should the Survey be revised, what implications or barriers would there be for the commenter’s organization to implement a new version of the Survey? 7. What information/documentation would be helpful to the respondent’s organization in making a transition to a future version of the Survey? AHRQ is interested in all of the questions listed above, but respondents are welcome to address as many or as few as they choose and to address additional areas of interest not listed. This RFI is for planning purposes only and should not be construed as a policy, solicitation for applications, or as an obligation on the part of the Government to provide support for any ideas in response to it. AHRQ will use the information submitted in response to this RFI at its discretion, and will not provide comments to any respondent’s submission. However, responses to the RFI may be reflected in future solicitation(s) or policies. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). The contents of all submissions will be made available to the public upon request. Submitted materials must be publicly available or able to be made public. Gopal Khanna, Director. [FR Doc. 2019–09855 Filed 5–13–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 ACTION: 21341 Notice of meeting. In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR). This meeting is open to the public, limited only by available seating. The meeting room accommodates approximately 60 people. The public is also welcome to listen to the meeting by calling 800– 810–6806, passcode 8137872, limited by 75 lines. The deadline for notification of attendance is May 24, 2019. The public comment period is scheduled on June 25, 2019 from 2:30 p.m. until 2:45 p.m., EDT and June 26, 2019 from 10:10 a.m. until 10:25 a.m., EDT. Individuals wishing to make a comment during Public Comment period, please email your name, organization, and phone number by May 24, 2019 to Shirley Little at snl7@cdc.gov. DATES: The meeting will be held on June 25, 2019, 8:30 a.m. to 4:00 p.m., EDT and June 26, 2019, 8:30 a.m. to 11:30 a.m., EDT. ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341–3717. FOR FURTHER INFORMATION CONTACT: Shirley Little, Program Analyst, NCEH/ ATSDR, CDC, 4770 Buford Highway, Mailstop F–45, Atlanta, Georgia 30341– 3717, Telephone (770) 488–0577; Email snl7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, NCEH/ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and wellbeing; and (3) train state and local personnel in health work. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and SUMMARY: E:\FR\FM\14MYN1.SGM 14MYN1 21342 Federal Register / Vol. 84, No. 93 / Tuesday, May 14, 2019 / Notices priorities in fulfillment of the agency’s mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Matters to be Considered: The agenda will include discussions on NCEH/ ATSDR Program Responses to BSC Guidance and Action Items; PFAS Health Related Initiatives; Expanding National Laboratory Capacity to Measure Human Exposure to Synthetic Opioids; CCARE: Controlling Childhood Asthma, Reducing Emergencies; The Intersection of Place and Health: ATSDR’s Geospatial Research Analysis and Services Program (GRASP); and Social Vulnerability Index (SVI) and Ethylene Oxide. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–09847 Filed 5–13–19; 8:45 am] FOR FURTHER INFORMATION CONTACT: BILLING CODE 4163–19–P Todd Lertjuntharangool, Regional Program Manager, Region XI/AIAN, Office of Head Start, email Todd.Lertjuntharangool@acf.hhs.gov, or phone (202) 205–9503. Additional information and online meeting registration will be available at https:// eclkc.ohs.acf.hhs.gov/hslc/hs/calendar/ tc2019. DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Tribal Consultation Meetings Office of Head Start (OHS), Administration for Children (ACF) and Families, Department of Health and Human Services (HHS). ACTION: Notice of meetings. AGENCY: Pursuant to the Improving Head Start for School Readiness Act of 2007, notice is hereby given of six 1-day Tribal Consultation (TC) Sessions to be held between the HHS)/ACF, OHS leadership and the leadership of tribal governments operating Head Start (including Early Head Start) programs. The purpose of these consultation sessions is to discuss ways to better meet the needs of American Indian and Alaska Native children and their families, taking into consideration SUMMARY: khammond on DSKBBV9HB2PROD with NOTICES funding allocations, distribution formulas, and other issues affecting the delivery of Head Start services in their geographic locations. Six TCs will be held as part of HHS/ACF and/or ACF TC Sessions. DATES: June 19, 2019, from 1:00 p.m. to 3:00 p.m. June 27, 2019, from 9:00 a.m. to 12:00 p.m. July 10, 2019, from 1:00 p.m. to 3:00 p.m. July 16, 2019, from 1:00 p.m. to 3:00 p.m. August 21, 2019, from 9 a.m. to 11 a.m. September 16, 2019, Date and time to be determined ADDRESSES: • June 19, 2019—Sacramento, CA (Location to be provided at a later date) • June 27, 2019—National Indian Head Start Directors Association, Scottsdale, AZ (Location to be provided at a later date) • July 10, 2019—Spokane, WA (Location to be provided at a later date) • July 16, 2019—Washington, DC (Location to be provided at a later date) • August 21, 2019—Denver, CO (Location to be provided at a later date) • September 16, 2019—Temecula, CA (Location to be provided at a later date) VerDate Sep<11>2014 16:57 May 13, 2019 Jkt 247001 In accordance with the Improving Head Start for School Readiness Act of 2007, Public Law 110–134 [42 U.S.C. 9835, § 640(l)(4)], ACF announces OHS tribal consultations for leaders of tribal governments operating Head Start and Early Head Start programs. The agenda for the scheduled OHS tribal consultations in Sacramento, California; Scottsdale, Arizona; Spokane, Washington; Washington, DC; Denver, Colorado; and Temecula, California will be organized around the statutory purposes of Head Start tribal consultations related to meeting the needs of American Indian and Alaska Native children and families, taking into consideration funding allocations, SUPPLEMENTARY INFORMATION: PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 distribution formulas, and other issues affecting the delivery of Head Start services in their geographic locations. In addition, OHS will share actions taken and in progress to address the issues and concerns raised in the 2018 OHSTCs. The consultation sessions will be conducted with elected or appointed leaders of tribal governments and their designated representatives. Designees must have a letter from the tribal government authorizing them to represent the tribe. Tribal governments must submit the designee letter at least 3 days in advance of the consultation sessions to Todd Lertjuntharangool at Todd.Lertjuntharangool@acf.hhs.gov. Other representatives of tribal organizations and Native non-profit organizations are welcome to attend as observers. A detailed report of each consultation session will be prepared and made available within 45 days of the consultation sessions to all tribal governments receiving funds for Head Start and Early Head Start programs. Tribes wishing to submit written testimony for the report should send testimony to Todd Lertjuntharangool at Todd.Lurtjuntharangool@acf.hhs.gov either prior to each consultation session or within 30 days after each meeting. OHS will summarize oral testimony and comments from the consultation sessions in each report without attribution, along with topics of concern and recommendations. Dated: May 7, 2019. Deborah Bergeron Director, Office of Head Start. [FR Doc. 2019–09927 Filed 5–13–19; 8:45 am] BILLING CODE 4184–40–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2017–D–0154] Considerations in Demonstrating Interchangeability With a Reference Product; Guidance for Industry; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled ‘‘Considerations in Demonstrating Interchangeability With a Reference Product.’’ This guidance is intended to SUMMARY: E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 84, Number 93 (Tuesday, May 14, 2019)]
[Notices]
[Pages 21341-21342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-09847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Environmental 
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Environmental Health/Agency for Toxic Substances 
and Disease Registry (BSC, NCEH/ATSDR). This meeting is open to the 
public, limited only by available seating. The meeting room 
accommodates approximately 60 people. The public is also welcome to 
listen to the meeting by calling 800-810-6806, passcode 8137872, 
limited by 75 lines. The deadline for notification of attendance is May 
24, 2019. The public comment period is scheduled on June 25, 2019 from 
2:30 p.m. until 2:45 p.m., EDT and June 26, 2019 from 10:10 a.m. until 
10:25 a.m., EDT. Individuals wishing to make a comment during Public 
Comment period, please email your name, organization, and phone number 
by May 24, 2019 to Shirley Little at [email protected].

DATES: The meeting will be held on June 25, 2019, 8:30 a.m. to 4:00 
p.m., EDT and June 26, 2019, 8:30 a.m. to 11:30 a.m., EDT.

ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341-3717.

FOR FURTHER INFORMATION CONTACT: Shirley Little, Program Analyst, NCEH/
ATSDR, CDC, 4770 Buford Highway, Mailstop F-45, Atlanta, Georgia 30341-
3717, Telephone (770) 488-0577; Email [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Secretary, Department of Health and Human Services 
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 
(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) 
Conduct, encourage, cooperate with, and assist other appropriate public 
authorities, scientific institutions, and scientists in the conduct of 
research, investigations, experiments, demonstrations, and studies 
relating to the causes, diagnosis, treatment, control, and prevention 
of physical and mental diseases and other impairments; (2) assist 
states and their political subdivisions in the prevention of infectious 
diseases and other preventable conditions and in the promotion of 
health and wellbeing; and (3) train state and local personnel in health 
work. The BSC, NCEH/ATSDR provides advice and guidance to the 
Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the 
Director, NCEH/ATSDR, regarding program goals, objectives, strategies, 
and

[[Page 21342]]

priorities in fulfillment of the agency's mission to protect and 
promote people's health. The board provides advice and guidance that 
will assist NCEH/ATSDR in ensuring scientific quality, timeliness, 
utility, and dissemination of results. The board also provides guidance 
to help NCEH/ATSDR work more efficiently and effectively with its 
various constituents and to fulfill its mission in protecting America's 
health.
    Matters to be Considered: The agenda will include discussions on 
NCEH/ATSDR Program Responses to BSC Guidance and Action Items; PFAS 
Health Related Initiatives; Expanding National Laboratory Capacity to 
Measure Human Exposure to Synthetic Opioids; CCARE: Controlling 
Childhood Asthma, Reducing Emergencies; The Intersection of Place and 
Health: ATSDR's Geospatial Research Analysis and Services Program 
(GRASP); and Social Vulnerability Index (SVI) and Ethylene Oxide. 
Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-09847 Filed 5-13-19; 8:45 am]
 BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.